Literature DB >> 4296524

Renal-pressor hypertension secondary to unilateral hydronephrosis.

A B Belman, K A Kropp, N M Simon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4296524     DOI: 10.1056/NEJM196805232782101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Unrecognised high pressure chronic retention of urine presenting with systemic arterial hypertension.

Authors:  R R Ghose; V Harindra
Journal:  BMJ       Date:  1989-06-17

2.  Animal model of human disease. Hydronephrosis, agenesis of the renal medulla, arterial hypertension.

Authors:  D Kentera; D Susic; E Machado; B B Lozzio
Journal:  Am J Pathol       Date:  1977-05       Impact factor: 4.307

3.  Rare forms of renal hypertension.

Authors:  T Lüscher; H Vetter; G Pouliadis; U Kuhlmann; A Studer; D Hauri; B Wicky; I Schmitt; N Satz; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-01-02

4.  Hypertension and hydronephrosis: rapid resolution of high blood pressure following relief of bilateral ureteric obstruction.

Authors:  Anil Chalisey; Mahzuz Karim
Journal:  J Gen Intern Med       Date:  2012-08-10       Impact factor: 5.128

5.  Acute bilateral ureteropelvic junction obstruction as a rare cause of hypertensive crisis: a case report.

Authors:  Bruce Adrian Casipit; Jerald Pelayo; Joseph Alexander Paguio; Jasper Seth Yao; Niel Shah
Journal:  J Med Case Rep       Date:  2022-05-23

6.  The pattern of plasma renin activity and aldosterone system in patients with sustained hydronephrosis.

Authors:  M Ezzat
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

7.  Secondary hypertension accompanying high pressure chronic retention.

Authors:  R R Ghose; J L Birks
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

8.  The radiological evaluation of children with hypertension.

Authors:  P Lanning; M Uhari
Journal:  Eur J Pediatr       Date:  1979-11       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.